Literature DB >> 16457890

Synthesis, characterization and DNA-binding of novel chiral complexes delta- and lambda-[Ru(bpy)2L]2+ (L = o-mopip and p-mopip).

Shuo Shi1, Jie Liu, Jun Li, Kang-Cheng Zheng, Xiao-Mei Huang, Cai-Ping Tan, Lan-Mei Chen, Liang-Nian Ji.   

Abstract

Novel chiral Ru(II) complexes [Ru(bpy)2L]2+ (bpy = 2,2-bipyridine; L: o-mopip = 2-(2-methoxylphenyl)imidazo[4,5-f][1,10]phenanthroline, p-mopip = 2-(4-methoxylphenyl)imidazo[4,5-f][1,10]phenanthroline) containing -OCH3 at different positions on the phenyl ring have been synthesized and characterized. The DNA-binding and DNA-photocleavage properties of the complexes were investigated. The theoretical calculations for these complexes were also carried out applying the density functional theory (DFT) method. The experimental results show that: both these two isomer complexes can bind to DNA in an intercalative mode; the DNA-binding affinity of [Ru(bpy)2(p-mopip)] 2 is greater than that of [Ru(bpy)2(o-mopip)] 1; moreover, the DNA-binding affinities of enantiomers delta-1 and delta-2 are all greater than those of lambda-1 and lambda-2, respectively. In addition, a very interesting finding is experimentally obtained, i.e. under a low [DNA]/[Ru] ratio, the emission intensities of delta-1 and lambda-1 are all weaker than those of delta-2 and lambda-2, however, upon a high [DNA]/[Ru] ratio, the emission intensities of both delta-1 and lambda-1 are stronger than those of delta-2 and lambda-2. Such a difference of the emission spectra can be interpreted by the electric effect of substituent on the intercalative ligand. The difference in DNA-binding affinities of these two isomeric complexes can also be reasonably explained by the DFT calculations.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16457890     DOI: 10.1016/j.jinorgbio.2005.12.005

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  7 in total

1.  Systematic characterization on electronic structures and spectra for a series of complexes, M(IDB)Cl2 (M = Mn, Fe, Co, Ni, Cu and Zn): a theoretical study.

Authors:  Yanyan Zhu; Zhanfen Chen; Zijian Guo; Yan Wang; Guangju Chen
Journal:  J Mol Model       Date:  2008-12-13       Impact factor: 1.810

2.  Structural analysis and biological functionalities of iron(III)- and manganese(III)-thiosemicarbazone complexes: in vitro anti-proliferative activity on human cancer cells, DNA binding and cleavage studies.

Authors:  Büşra Kaya; Zehra Kübra Yılmaz; Onur Şahin; Belma Aslim; Ümmügülsüm Tükenmez; Bahri Ülküseven
Journal:  J Biol Inorg Chem       Date:  2019-03-20       Impact factor: 3.358

3.  BSA/DNA binding behavior and the photophysicochemical properties of novel water soluble zinc(II)phthalocyanines directly substituted with piperazine groups.

Authors:  Khaoula Khezami; Kevser Harmandar; Esra Bağda; Efkan Bağda; Gamze Şahin; Nurşen Karakodak; Mahmut Durmuş
Journal:  J Biol Inorg Chem       Date:  2021-05-04       Impact factor: 3.358

4.  Identification of Binding Mode of a Platinum (II) Complex, PtCl(2)(DIP), and Calf Thymus DNA.

Authors:  Nahid Shahabadi; Soheila Kashanian; Azadeh Fatahi
Journal:  Bioinorg Chem Appl       Date:  2011-10-24       Impact factor: 7.778

5.  DNA Interaction and DNA Cleavage Studies of a New Platinum(II) Complex Containing Aliphatic and Aromatic Dinitrogen Ligands.

Authors:  Nahid Shahabadi; Soheila Kashanian; Maryam Mahdavi; Noorkaram Sourinejad
Journal:  Bioinorg Chem Appl       Date:  2011-12-22       Impact factor: 7.778

6.  Synthesis and Spectroscopic Investigations of Schiff Base Ligand and Its Bimetallic Ag(I) Complex as DNA and BSA Binders.

Authors:  Martyna Szymańska; Izabela Pospieszna-Markiewicz; Martyna Mańka; Małgorzata Insińska-Rak; Grzegorz Dutkiewicz; Violetta Patroniak; Marta A Fik-Jaskółka
Journal:  Biomolecules       Date:  2021-10-02

7.  Carbazole Derivatives' Binding to c-KIT G-Quadruplex DNA.

Authors:  Agata Głuszyńska; Bernard Juskowiak; Martyna Kuta-Siejkowska; Marcin Hoffmann; Shozeb Haider
Journal:  Molecules       Date:  2018-05-10       Impact factor: 4.411

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.